VIR – vir biotechnology, inc. (US:NASDAQ)
Stock Stats
News
Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones [Yahoo! Finance]
Vir Biotechnology Provides Updates on Chronic Hepatitis Delta and Oncology Programs and Upcoming 2026 Clinical Milestones
Vir Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
Vir Biotechnology (NASDAQ:VIR) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Norgine enhances hepatology and specialty portfolio through exclusive in-licensing agreement with Vir Biotechnology [Yahoo! Finance]
Form 144 Vir Biotechnology, Inc. Filed by: SVF Endurance (Cayman) Ltd
Form 8-K Vir Biotechnology, Inc. For: Jan 12
Form 4 Vir Biotechnology, Inc. For: Jan 02 Filed by: SATO VICKI L
Form 144 Vir Biotechnology, Inc. Filed by: SATO VICKI L
Form 8-K Vir Biotechnology, Inc. For: Dec 16
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.